AGENT™ H7493960812300Recalls & reported problems
Boston Scientific Corporation · Paclitaxel-Coated Balloon Catheter · Class 3
All models of AGENT (23)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00191506014681), received between Apr 21, 2025 and Aug 19, 2026 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Break” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break4
- Adverse Event Without Identified Device or Use Problem2
- Deformation Due to Compressive Stress1
- Entrapment of Device1
- Failure to Advance1
- Use of Device Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 19, 2026Break; Failure to Advance
It was reported that a shaft break within a patient occurred. A 3.00 mm x 12mm AGENT US MR was selected for a Percutaneous Coronary Intervention to evaluate the target lesion. During the procedure, the device could not advance in the lesion and the shaft subsequently broke. The procedure was completed as planned and the device was successfully removed in one piece from the patient. No patient complications reported.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50334624 ↗MalfunctionMay 4, 2026Break; Deformation Due to Compressive Stress
IT WAS REPORTED THAT THE BALLOON KINKED AND THE SHAFT BROKE. A 3.00 MM X 12.00 MM AGENT DRUG-COATED BALLOON (DCB) WAS SELECTED FOR TREATMENT. DURING ADVANCEMENT OF THE DEVICE INTO THE PATIENT, THE SHAFT KINKED AND SUBSEQUENTLY BROKE. THE DEVICE WAS REMOVED, AND THE PROCEDURE WAS SUCCESSFULLY COMPLETED USING AN ALTERNATIVE DEVICE. THERE WERE NO PATIENT COMPLICATIONS AND THE PATIENT FULLY RECOVERED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25070664 ↗MalfunctionJul 2, 2025Break; Adverse Event Without Identified Device or Use Problem; Break; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 3.00 X 12MM AGENT DRUG-COATED BALLOON (DCB) WAS SELECTED FOR PERCUTANEOUS CORONARY INTERVENTION PROCEDURE. DURING PROCEDURE, BALLOON SHAFT BROKE. DEVICE WAS REMOVED OUT OF PATIENT AND NOTHING WAS LEFT IN THE PATIENT. THE PROCEDURE WAS COMPLETED WITH ALTERNATE DEVICE AND THERE WAS NO PATIENT COMPLICATION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22383075 ↗MalfunctionApr 21, 2025Break; Entrapment of Device; Use of Device Problem; Adverse Event Without Identified Device or Use Problem; Break; Entrapment of Device; Use of Device Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT CATHETER FROZE ON WIRE OCCURRED. A 3.00 X 12MM AGENT DCB BALLOON WAS SELECTED FOR PERCUTANEOUS CORONARY INTERVENTION PROCEDURE TO TREAT CORONARY ARTERY DISEASE AND IN-STENT RESTENOSIS. DURING THE PROCEDURE, WHEN THE PHYSICIAN ADVANCED THE BALLOON, IT WAS NOT NOTED THAT THE BALLOON PROTECTOR WAS STILL ON THE DEVICE. THE COVER WOULD NOT ADVANCE THROUGH THE TOUHY. THE PHYSICIAN TRIED TO PEEL AWAY THE COVER WHILE THE DEVICE WAS ON THE GUIDEWIRE BUT WAS NOT SUCCESSFUL. THE COVER HAD BEEN PUSHED TO THE MONORAIL EXIT PORT OF THE BALLOON AND THE BALLOON WAS STUCK ON THE GUIDEWIRE. DURING ATTEMPTS TO REMOVE THE BALLOON FROM THE GUIDEWIRE OUTSIDE THE PATIENT, THE BALLOON MONORAIL/HYPOTUBE BROKE AWAY FROM THE SHAFT AND THE GUIDEWIRE ALSO SNAPPED. THE PROCEDURE WAS COMPLETED USING A NEW GUIDEWIRE AND A NEW AGENT BALLOON. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21876972 ↗
Other Drug-eluting percutaneous transluminal coronary angioplasty catheter devices
- AGENT™ H7493960830250Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter10 reports
- AGENT™ H7493960830300Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter8 reports
- AGENT™ H7493960820300Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter8 reports
- AGENT™ H7493960820250Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter6 reports
- AGENT™ H7493960830400Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter6 reports
- AGENT™ H7493960830350Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter5 reports
- AGENT™ H7493960820400Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter5 reports
- AGENT™ H7493960815300Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page